Latest Licensing News

General Capital Limited reported an 18% increase in revenue to $26.8 million for the year ended March 2026, while net profit after tax held steady at $2.7 million amid economic uncertainty and a goodwill impairment. The company declared a fully imputed final dividend, signalling confidence despite regulatory challenges.

Avecho Biotechnology has wrapped up the treatment phase for its pivotal Phase III insomnia trial involving 244 participants, setting the stage for an interim efficacy analysis expected in late June 2026.

Lion Rock Minerals has brought in a seasoned leadership team from Sierra Rutile to spearhead development at its Minta Rutile and Monazite Project in Cameroon, supported by a $2 million capital raise.

AFT Pharmaceuticals posted a 22% revenue jump to NZ$254.7 million and a 39% increase in operating profit to a record NZ$24.4 million for FY26, exceeding guidance. The company targets over NZ$300 million revenue for FY27, fueled by international expansion and a deepening R&D pipeline.

Ballard Mining's March quarter update reveals a robust 1.2 million ounce gold resource at Mt Ida and a healthy $75.6 million cash position, setting the stage for a Final Investment Decision in H1 2027.

Stelar Metals (ASX:SLB) is accelerating exploration at its Hill of Leaders Tungsten Project in the Northern Territory, aiming to capitalise on soaring tungsten prices and critical mineral demand driven by Chinese export restrictions.

Hydrix Limited has bolstered its balance sheet by raising $3.89 million and converting $5.1 million of debt into equity, positioning itself to expand its Defence technology footprint following a $1.2 million contract with NIOA Group.

Invion Limited has partnered with South Korea's SANGMYUNG Innovation to explore its Photosoft™ photodynamic therapy for wet age-related macular degeneration, addressing a large unmet medical need in ophthalmology.

Strickland Metals (ASX:STK) has confirmed no hidden material information explains recent share price swings, attributing volatility to regulatory delays in Serbia and broader gold sector weakness.

Parkway Corporate has teamed up with Hitachi to develop modular ultra-high brine concentration systems, crucial for its flagship Queensland Brine Management Complex project aimed at transforming industrial waste brine into green chemicals.

Singapore’s telecom regulator has paused its assessment of Tuas Limited’s acquisition of M1 Limited amid concerns over unauthorized spectrum use by Simba, a related entity. This regulatory hurdle casts uncertainty on the transaction’s imminent completion.

Pro Medicus’ US arm Visage Imaging has landed a significant 7-year, A$90 million contract to deploy its cloud-based Visage 7 platform across Beth Israel Lahey Health, marking another major foothold in North America's healthcare imaging market.